Gary J Pruden Johnson & Johnson (JNJ) insider trading activity

Gary J Pruden is Exec VP, WW Chair, Med Devices of JOHNSON & JOHNSON. Currently has a direct ownership of 43,630 shares of JNJ, which is worth approximately $6.36 Million. The most recent transaction as insider was on Feb 28, 2017, when has been sold 16,299 shares (Common Stock) at a price of $122.21 per share, resulting in proceeds of $1,991,901. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.6K

0% 3M change

0% 12M change

Total Value Held $6.36 Million

Gary J Pruden Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2017	SELL Open market or private sale	$1,991,901 $122.21 p/Share	16,299 Reduced 27.2%	43,630 Common Stock
Feb 13 2017	SELL Payment of exercise price or tax liability	$1,118,876 $115.67 p/Share	9,673 Reduced 13.9%	59,929 Common Stock
Feb 13 2017	BUY Grant, award, or other acquisition	-	6,197 Added 8.18%	69,602 Common Stock
Feb 13 2017	BUY Exercise of conversion of derivative security	-	15,532 Added 19.68%	63,405 Common Stock
Feb 10 2017	SELL Payment of exercise price or tax liability	$226,806 $115.13 p/Share	1,970 Reduced 3.95%	47,873 Common Stock
Feb 10 2017	BUY Exercise of conversion of derivative security	-	6,213 Added 11.08%	49,843 Common Stock
Jun 07 2016	SELL Open market or private sale	$1,129,552 $116.03 p/Share	9,735 Reduced 18.24%	43,630 Common Stock

Also insider at

LNTH

Lantheus Holdings, Inc. Healthcare

MOTS

Motus GI Holdings, Inc. Healthcare

Director

GJP

Gary J Pruden

Exec VP, WW Chair, Med Devices

New Brunswick, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Value

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

Operation

Value

Type

News

Receive news related to JOHNSON & JOHNSON

Track Activities on JNJ

Account